OncoNano Medicine
Tian Zhao, Ph.D., is an experienced translational research and development professional with broad experience in nanomedicine, cancer imaging, and drug discovery. In this position, Dr. Zhao leads the strategic vision and tactical execution of the R&D team and is responsible for directing all phases of technical product development at the company. Previously, Dr. Zhao worked at UT Southwestern Medical Center and Texas Tech University. Dr. Zhao received a B.S. in Chemistry from Wuhan University, an M.S. in Chemistry from Texas Tech University, and a Ph.D. from the University of Texas Southwestern Medical Center. He has authored more than 30 scientific publications resulting in more than 1500 citations. Dr. Zhao is also an inventor of the technologies licensed to OncoNano.
This person is not in any offices
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.